Descripción del proyecto
Cerrar las brechas para una innovación sanitaria de vanguardia
La carrera de Europa por mantener su competitividad en la escena mundial recibirá un impulso con la puesta en marcha del proyecto NOBEL, financiado con fondos europeos. Tras reconocer la necesidad de nanomedicinas innovadoras y tecnologías médicas de vanguardia, esta ambiciosa iniciativa pretende revolucionar el sector. En NOBEL se creará un ecosistema sin fisuras que conecte a todas las partes interesadas y elimine barreras a lo largo de la cadena de valor. Para ello, se aprovechará el potencial de las nanotecnologías, la fotónica, la robótica, los materiales avanzados y las tecnologías de la información. En concreto, el equipo del proyecto pretende acelerar el desarrollo y la industrialización de las pymes pioneras en nanomedicina y tecnologías médicas. El resultado esperado es un resurgimiento de la economía europea, que generará valiosos puestos de trabajo y allanará el camino para un futuro mejor.
Objetivo
In order to compete globally, Europe has to innovate and develop nanomedicines and medical technologies with high value and high technological content, well protected IP, and ensuring both a clinical need and commercial opportunities of all new innovations. Technically, this will be achieved by combining elements of key enabling technologies like nanotechnologies, photonics, robotics, advanced materials and information technologies to get smart medical devices and smart nanomedicines. However, the translation of the preclinical proof of concepts to the market via clinical validation, regulatory approval, and approval for reimbursement by the healthcare systems, requires a more integrated and streamlined ecosystem with less barriers between stakeholders and steps. Following their successful experience in the past 12 years of development in nanomedicine and medical technologies, ETPN and the seven other partners of NOBEL are merging their networks to set up a coherent, robust and unique ecosystem where information flow will improve awareness all along the value chain right up to the market access. It develops interactions, cooperation and implementation of complementary actions at local, regional, national, European and even international levels. The building of this ecosystem is based on two main pillars: a joint vision of the strategy for the future (roadmapping) and a high cohesion and interrelationship among the members of the ecosystem. One of the most significant and impactful outputs of this inclusive efficient ecosystem is the tangible acceleration of the development and industrialization of innovative SMEs in nanomedicine and medical technologies. This will impact the renaissance of EU economy by creating jobs and value in Europe. NOBEL will be unique in building the most efficient network of connections and synergies all along the value chain of Nanomedicine and healthcare technologies in Europe.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-NMBP-CSA-2017
Régimen de financiación
CSA - Coordination and support actionCoordinador
75005 Paris
Francia